Alprazolam 2 mg Oral tablets (immediate-release) bulk supplier for pharma manufacturers

Alprazolam 2 Mg Oral Tablets (Immediate-Release) 0.25 mg, 0.5 mg, 1 mg, 2 mg Suppliers & Bulk Manufacturers

Available Forms: Oral tablets (immediate-release)

Available Strengths: 0.25 mg, 0.5 mg, 1 mg, 2 mg

Reference Brands: Xanax®(US & EU), Niravam®, Alprazolam Intensol®

Alprazolam enhances GABA activity by binding to benzodiazepine receptors, producing anxiolytic, sedative, and muscle-relaxant effects. It is primarily used for treating anxiety disorders, panic disorders, and short-term relief of anxiety symptoms. Its fast onset makes it effective for acute anxiety episodes and panic attacks.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Alprazolam immediate-release tablets are FDA-approved in the USA for managing anxiety disorders and short-term relief of anxiety symptoms. They are also used in treating panic disorders, often as part of a broader therapeutic plan. Classified as a Schedule IV controlled substance, Alprazolam is subject to prescription-only access due to its dependence risk. In the EU, it is approved under national procedures with similar indications, governed by stringent pharmacovigilance and controlled substance regulations. Regulatory oversight ensures appropriate prescribing and monitoring. For additional forms, global suppliers, and sourcing solutions, explore Pharmatradz.com, your partner in pharmaceutical B2B procurement.

Alprazolam 2 Mg Oral Tablets (Immediate-Release) — third party manufacturing & bulk supply

Alprazolam 2 Mg Oral Tablets (Immediate-Release) 0.25 mg, 0.5 mg, 1 mg, 2 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Alprazolam 2 Mg Oral Tablets (Immediate-Release) is supplied as Oral tablets (immediate-release) — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Alprazolam 2 Mg Oral Tablets (Immediate-Release) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Alprazolam 2 Mg Oral Tablets (Immediate-... →

Back to Listing

Frequently Asked Questions

Alprazolam is used for the management of anxiety disorders, panic disorders, and anxiety associated with depression. It helps reduce symptoms such as excessive worry, restlessness, irritability, and panic attacks.

Alprazolam is a synthetic benzodiazepine compound that works by enhancing the effect of gamma-aminobutyric acid (GABA), a neurotransmitter that slows down brain activity and produces a calming effect.

Common trade names include Xanax (widely known global brand), Niravam (orally disintegrating tablets), Alprax (India), Restyl (India), and Alzolam.

Alprazolam was originally developed and marketed by Pfizer under the brand Xanax. It is now manufactured by multiple pharmaceutical companies worldwide, including Teva, Mylan, Sun Pharma, Cipla, and many other generic manufacturers.

The generic name is alprazolam.

Brand names include Xanax, Niravam, Alprax, Restyl, Alzolam, and various other region-specific generics.

Alprazolam is manufactured globally, with major production in the United States, India, Europe, and other regions by both innovator and generic pharmaceutical companies.